Abstract:AIM:To optimize expression condition of HLA-A*0203 heavy chain ectodomain fused with a BirA substrate peptide (BSP) (HLA-A*0203-BSP) for E.coli BL21(DE3) transformant and to prepare a functional HLA-A*0203 tetramer loaded with an antigenic peptide derived from EBNA3(596-604) of Epstein-Barr virus (EBV).METHODS:The temperature, IPTG concentration and inductive duration of HLA-A*0203-BSP fusion protein expressed for E.coli BL21(DE3) transformant were optimized. SDS-PAGE and Western blot analyses were employed to detect the expressed fusion protein. The monomer of soluble HLA-A*0203-peptide was generated from the fusion protein by in vitro refolding of washed inclusion bodies in the presence of beta2-microglobulin (beta2m) and HLA-A*0203 restricted EBV EBNA3(596-604) peptide (SVRDRLARL, SVR). Refolded and purified monomer was then biotinylated with BirA. Following the purification of the obtained biotinylated monomer, the tetramer was formed by incubation with streptavidin-PE at a ratio of 4:1. Flow cytometry (FCM) analysis was performed to determine its binding activity with specific cytotoxic T lymphocytes (CTL).RESULTS:SDS-PAGE and Western blot showed that the optimized expression condition was overnight induction at 37 degrees C with 0.4 mmol/L IPTG. The expressed protein of about 34 kDa in the form of inclusion bodies accumulated up to about 30% of total bacterial protein under the optimized expression condition. The monomer of soluble HLA-A*0203/SVR was successfully generated and purified. Non-reducing SDS-PAGE analysis showed that the biotinylation was above 85%. HLA-A*0203/SVR tetramer was constructed by mixing the monomer with streptavidin-PE at a ratio of 4:1. FCM analysis indicated that this tetramer could bind specific CTL from HLA-A2+ donors.CONCLUSION:HLA-A*0203-BSP fusion protein was overexpressed in E.coli under the optimized condition. The tetramers of HLA-A*0203/SVR were prepared from this fusion protein and it possessed binding activity with specific CTL, which provided a powerful tool for direct visualization and quantification of specific CTL from HLA-A*0203 donors.

A novel one-step strategy for the preparation of HLA/HBc 18–27 and HLA/CEA 694–702 complexes with ion exchange chromatography

Development of a Hybrid Biomimetic Ligand with High Selectivity and Mild Elution for Antibody Purification

A New Tetrapeptide Biomimetic Chromatographic Resin for Antibody Separation with High Adsorption Capacity and Selectivity

New Tetrapeptide Ligands Designed for Antibody Purification with Biomimetic Chromatography: Molecular Simulation and Experimental Validation

A Novel Dextran-Grafted Tetrapeptide Resin for Antibody Purification

High-throughput Screening and Optimization of Mixed-Mode Resins for Human Serum Albumin Separation with Microtiter Filter Plate

Enhancing IgG purification from serum albumin containing feedstock with hydrophobic charge-induction chromatography.

High-Throughput Process Development for Recombinant Human Serum Albumin Separation from Pichia Pastoris Broth with Mixed-Mode Chromatography

Two-step separation strategy with mixed-mode chromatography to purify recombinant human serum albumin from <i>Pichia pastoris</i> culture broth

[Improvement of Refolding Efficiency of HLA-A2-peptide Complex in Vitro by Preformed Disulfide Bonds in Heavy Chain].

In-vitro refolding and biotinylation of soluble HLA-A2-peptide complex]

Preparation of the Soluble HLA-A*0201-Antigenic Peptide Complex

Preparation of Biotinylated HLA--A*2402--peptide Complex

In vitro Refolding and Tetramerization of Soluble HLA-A*2402-pBRLF1 Complex

Biomimetic Affinity Chromatography for Antibody Purification: Host Cell Protein Binding and Impurity Removal.

Refolding and identification of soluble HLA-G1-peptide complex in vitro

Preparation and Purification of Biotinylated Soluble H-2Kd-peptide Complex

Biomimetic affinity chromatography for antibody purification: host cell proteins binding and impurity removal

[Expression and Refolding of a HLA-A*0203-BSP Fusion Protein and Identification of Its Tetramers].

[Construction and Characterization of Soluble HLA-A*0201-PR1 Complex].

One kind of challenging tetrapeptide biomimetic chromatographic resin for antibody separation